Antibody expression kinetics in glycoengineered Pichia pastoris

Thomas I Potgieter1, Sean D Kersey, Muralidhar R Mallem

  • 1Bioprocess Research and Development, Merck & Co, 126 E. Lincoln Avenue, Rahway, New Jersey 07065, USA. thomas_potgieter@merck.com

Summary

This study introduces a simplified method to predict antibody production in glycoengineered yeast, optimizing growth and oxygen needs for large-scale bioprocessing. The findings help improve efficiency in producing therapeutic proteins.

Related Concept Videos